Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2009 1
2010 2
2011 2
2012 1
2014 1
2015 1
2016 1
2017 2
2018 5
2019 1
2020 4
2021 4
2022 2
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Feasibility of accelerated partial breast irradiation with strut-adjusted volume implant brachytherapy in Japan focusing on dosimetry and acute toxicity: a Japanese multi-institutional prospective study.
Yoshida M, Yoshimura RI, Notake R, Shinjo H, Miyaura K, Kuwayama T, Kawanaka T, Shien T, Yoshio K, Shiga T, Kaneyasu Y, Nakagawa T, Kubota K, Nakamura S, Itami J; Working group of APBI with SAVIs in Japan (WASAVIs). Yoshida M, et al. Among authors: kuwayama t. Breast Cancer. 2024 Jan;31(1):75-83. doi: 10.1007/s12282-023-01513-x. Epub 2023 Oct 21. Breast Cancer. 2024. PMID: 37865624
Copy number alteration is an independent prognostic biomarker in triple-negative breast cancer patients.
Nagahashi M, Ling Y, Toshikawa C, Hayashida T, Kitagawa Y, Futamura M, Kuwayama T, Nakamura S, Yamauchi H, Yamauchi T, Kaneko K, Kanbayashi C, Sato N, Tsuchida J, Moro K, Nakajima M, Shimada Y, Ichikawa H, Lyle S, Miyoshi Y, Takabe K, Okuda S, Wakai T. Nagahashi M, et al. Among authors: kuwayama t. Breast Cancer. 2023 Jul;30(4):584-595. doi: 10.1007/s12282-023-01449-2. Epub 2023 Mar 17. Breast Cancer. 2023. PMID: 36930419
Diagnostic performance of dedicated breast positron emission tomography.
Hashimoto R, Akashi-Tanaka S, Watanabe C, Masuda H, Taruno K, Takamaru T, Ide Y, Kuwayama T, Kobayashi Y, Takimoto M, Nakamura S. Hashimoto R, et al. Among authors: kuwayama t. Breast Cancer. 2022 Nov;29(6):1013-1021. doi: 10.1007/s12282-022-01381-x. Epub 2022 Jun 29. Breast Cancer. 2022. PMID: 35768684 Free PMC article.
Magnetically Guided Localization Using a Guiding-Marker System® and a Handheld Magnetic Probe for Nonpalpable Breast Lesions: A Multicenter Feasibility Study in Japan.
Kurita T, Taruno K, Nakamura S, Takei H, Enokido K, Kuwayama T, Kanada Y, Akashi-Tanaka S, Matsuyanagi M, Hankyo M, Yanagihara K, Sakatani T, Sakamaki K, Kuwahata A, Sekino M, Kusakabe M. Kurita T, et al. Among authors: kuwayama t. Cancers (Basel). 2021 Jun 11;13(12):2923. doi: 10.3390/cancers13122923. Cancers (Basel). 2021. PMID: 34208090 Free PMC article.
Meta-analysis of nanoparticle albumin-bound paclitaxel used as neoadjuvant chemotherapy for operable breast cancer based on individual patient data (JBCRG-S01 study).
Futamura M, Oba M, Masuda N, Bando H, Okada M, Yamamoto Y, Kin T, Saeki T, Nagashima T, Kuwayama T, Toh U, Hirano A, Inokuchi M, Yamagami K, Mizuno Y, Kojima Y, Nakayama T, Yasojima H, Ohno S. Futamura M, et al. Among authors: kuwayama t. Breast Cancer. 2021 Sep;28(5):1023-1037. doi: 10.1007/s12282-021-01238-9. Epub 2021 Apr 3. Breast Cancer. 2021. PMID: 33811599 Free PMC article.
BRCAness as a prognostic indicator in patients with early breast cancer.
Liu L, Matsunaga Y, Tsurutani J, Akashi-Tanaka S, Masuda H, Ide Y, Hashimoto R, Inuzuka M, Watanabe C, Taruno K, Sawada T, Okuyama H, Ata A, Kuwayama T, Nakayama S, Tonouchi Y, Nakamura S. Liu L, et al. Among authors: kuwayama t. Sci Rep. 2020 Dec 3;10(1):21173. doi: 10.1038/s41598-020-78016-8. Sci Rep. 2020. PMID: 33273622 Free PMC article.
Risk Factors for Ipsilateral Breast Tumor Recurrence in Triple-Negative or HER2-Positive Breast Cancer Patients Who Achieve a Pathologic Complete Response After Neoadjuvant Chemotherapy.
Ishitobi M, Matsuda N, Tazo M, Nakayama S, Tokui R, Ogawa T, Yoshida A, Kojima Y, Kuwayama T, Nakayama T, Yamauchi H, Nakamura S, Tsugawa K, Hayashi N. Ishitobi M, et al. Among authors: kuwayama t. Ann Surg Oncol. 2021 May;28(5):2545-2552. doi: 10.1245/s10434-020-09176-0. Epub 2020 Oct 6. Ann Surg Oncol. 2021. PMID: 33021710
28 results